Beckman RA - Search Results

1

Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.

Beckman RA, Siden R, Yanik GA, Levine JE. Beckman RA, et al. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):344-50. doi: 10.1097/00043426-200007000-00013. J Pediatr Hematol Oncol. 2000. PMID: 10959906

2

Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors.

Beckman RA, Weiner LM, Davis HM. Beckman RA, et al. Cancer. 2007 Jan 15;109(2):170-9. doi: 10.1002/cncr.22402. Cancer. 2007. PMID: 17154393 Free article. Review.

3

Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer.

Gore M, Rustin G, Schüller J, Lane SR, Hearn S, Beckman RA, Ross G. Gore M, et al. Among authors: beckman ra. Br J Cancer. 2001 Apr 20;84(8):1043-6. doi: 10.1054/bjoc.2001.1726. Br J Cancer. 2001. PMID: 11308251 Free PMC article. Clinical Trial.

4

Efficiency of carcinogenesis with and without a mutator mutation.

Beckman RA, Loeb LA. Beckman RA, et al. Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14140-5. doi: 10.1073/pnas.0606271103. Epub 2006 Sep 11. Proc Natl Acad Sci U S A. 2006. PMID: 16966602 Free PMC article.

5

RNA unrestrained molecular dynamics ensemble improves agreement with experimental NMR data compared to single static structure: a test case.

Beckman RA, Moreland D, Louise-May S, Humblet C. Beckman RA, et al. J Comput Aided Mol Des. 2006 May;20(5):263-79. doi: 10.1007/s10822-006-9049-z. Epub 2006 Sep 28. J Comput Aided Mol Des. 2006. PMID: 17006738

6

Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors.

Mullamitha SA, Ton NC, Parker GJ, Jackson A, Julyan PJ, Roberts C, Buonaccorsi GA, Watson Y, Davies K, Cheung S, Hope L, Valle JW, Radford JA, Lawrance J, Saunders MP, Munteanu MC, Nakada MT, Nemeth JA, Davis HM, Jiao Q, Prabhakar U, Lang Z, Corringham RE, Beckman RA, Jayson GC. Mullamitha SA, et al. Among authors: beckman ra. Clin Cancer Res. 2007 Apr 1;13(7):2128-35. doi: 10.1158/1078-0432.CCR-06-2779. Clin Cancer Res. 2007. PMID: 17404096 Clinical Trial.

7

Alpha-v integrins as therapeutic targets in oncology.

Nemeth JA, Nakada MT, Trikha M, Lang Z, Gordon MS, Jayson GC, Corringham R, Prabhakar U, Davis HM, Beckman RA. Nemeth JA, et al. Among authors: beckman ra. Cancer Invest. 2007 Oct;25(7):632-46. doi: 10.1080/07357900701522638. Cancer Invest. 2007. PMID: 18027153 Review.

8

Combining Three-Dimensional Modeling with Artificial Intelligence to Increase Specificity and Precision in Peptide-MHC Binding Predictions.

Aranha MP, Jewel YSM, Beckman RA, Weiner LM, Mitchell JC, Parks JM, Smith JC. Aranha MP, et al. Among authors: beckman ra. J Immunol. 2020 Oct 1;205(7):1962-1977. doi: 10.4049/jimmunol.1900918. Epub 2020 Sep 2. J Immunol. 2020. PMID: 32878910 Free PMC article.

9

Antibody-based therapy for solid tumors.

Yan L, Hsu K, Beckman RA. Yan L, et al. Among authors: beckman ra. Cancer J. 2008 May-Jun;14(3):178-83. doi: 10.1097/PPO.0b013e318172d71a. Cancer J. 2008. PMID: 18536557 Review.

10

Monoclonal antibody dose determination and biodistribution into solid tumors.

Beckman RA, von Roemeling R, Scott AM. Beckman RA, et al. Ther Deliv. 2011 Mar;2(3):333-44. doi: 10.4155/tde.10.91. Ther Deliv. 2011. PMID: 22834004 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters